How to manage TB in children? Problems and solutions in four cases

• Autorzy: Danilo Buonsenso , Daniele Serranti , Benedetta Focarelli , Antonio Chiaretti , Roberta Calzedda , Piero Valentini
• Języki publikacji: EN

Abstrakty

EN

Children bear a substantial part of the tuberculosis (TB) epidemic worldwide, and it is estimated that there were ≅ 500.000 childhood TB cases globally in 2010, although accurate data are problematic to obtain given the many difficulties associated with TB diagnosis in children and the weaknesses of surveillance systems in countries where TB is endemic. The World Health Organization is working hard in order to reduce the TB prevalence rates and deaths by half by 2015. In this challenge, general practitioners and pediatricians play a key role in detecting early cases of suspected TB and sending them to experts in infectious diseases. This will reduce delayed diagnosis and the spread of disease, which is especially important now that the prevalence of multidrug resistant TB is increasing. For this reason, the purpose of this report was to delineate the characteristic clinical features of the most common forms of pediatric TB and to suggest a rational and practical approach to the disease underlining the role of patients and parents personal and clinical history.

Słowa kluczowe

EN

Tuberculosis; Children; Case-report; Management; Therapy

• Czasopismo: Open Medicine
• Rocznik: 2014
• Tom: 10
• Numer: 1

Daty

wydano

2015-01-01

otrzymano

2013-06-25

zaakceptowano

2014-09-12

online

2014-11-03

Twórcy

autor

Danilo Buonsenso

• Catholic University of Sacred Heart, Rome, Italy

autor

Daniele Serranti

• Catholic University of Sacred Heart, Rome, Italy

autor

Benedetta Focarelli

• Catholic University of Sacred Heart, Rome, Italy

autor

Antonio Chiaretti

• Catholic University of Sacred Heart, Rome, Italy

autor

Roberta Calzedda

• Catholic University of Sacred Heart, Rome, Italy

autor

Piero Valentini

• Catholic University of Sacred Heart, Rome, Italy

Bibliografia

• [1] World Health Organization. Global Tuberculosis Control: WHOReport 2011. Geneva, Switzerland: World Health Organization;2011. Publication WHO/HTM/TB/2011.16
• [2] Getahun H., Sculier D., Sismanidis C., Grzemska M., RaviglioneM., Prevention, diagnosis, and treatment of tuberculosisin children and mothers: evidence for action for maternal,neonatal, and child health services, J. Infect. Dis., 2012, 205,Suppl 2, 216-S227[WoS]
• [3] Merino J.M., Carpintero I., Alvarez T., Rodrigo J., Sanchez J.,Coello J.M., Tuberculous pleural effusion in children, Chest1999, 115, 26-30[Crossref]
• [4] Starke J.R., Jacobs R.F., Jeber J., Resurgence of tuberculosis inchildren, J. Pediatr., 1992, 120, 839[Crossref]
• [5] Bayazit N., Namiduru M., Mycobacterial cervical lymphadenitis,ORL. J. Otorhinolaryngol. Relat. Spec., 2004, 66, 275-280[Crossref]
• [6] Papadopouli E., Michailidi E., Papadopoulou E., PaspalakiP., Vlahakis I., Kalmanti M., Cervical lymphadenopathy inchildhood epidemiology and management, Pediatric Hematol.and Oncol., 2009, 26, 454-460
• [7] van Well G.T., Paes B.F., Terwee C.B., Springer P., Roord J.J.,Donald P.R., et al., Twenty years of pediatric tuberculousmeningitis: a retrospective cohort study in the western cape ofSouth Africa, Pediatrics 2009, 123, e1-8
• [8] Prasad K., Singh M.B., Corticosteroids for managingtuberculous meningitis, Cochrane Database Syst. Rev., 2006,CD002244
• [9] Shah I., Steroid therapy in children with tuberculousmeningitis, Scand. J. Infect. Dis., 2009, 41, 532-534[Crossref]
• [10] Buonsenso D., Serranti D., Valentini P., Management of centralnervous system tuberculosis in children: light and shade, Eur.Rev. Med. Pharmacol. Sci., 2010, 14, 845-853
• [11] Van der Merwe D.J., Andronikou S., Van Toorn R., Pienaar M.,Brainstem ischemic lesions on MRI in children with tuberculousmeningitis: with diffusion weighted confirmation. Childs Nerv.Syst., 2009, 25, 949-954[Crossref]
• [12] Chintu C., Tuberculosis and human immunodeficiency virusco-infection in children: management challenges, Paediatr.Respir. Rev., 2007, 8, 142-147[WoS][Crossref]
• [13] Pillay T., Khan M., Moodley J., Adhikari M., Coovadia H.,Perinatal tuberculosis and HIV-1: considerations for resourcelimitedsettings, Lancet Infect. Dis., 2004, 4, 155-165[Crossref]
• [14] Ahmed Y., Mwaba P., Chintu C., Grange J.M., UstianowskiA., Zumla A., A study of maternal mortality at the UniversityTeaching Hospital, Lusaka, Zambia: the emergence oftuberculosis as a major non-obstetric cause of maternal death,Int. J. Tuberc. Lung. Dis., 1999, 3, 675-680
• [15] Vilarinho L.C., Congenital tuberculosis: a case report, Braz. J.Infect. Dis., 2006, 10, 368-70.[Crossref]
• [16] Singh M., Kothur K., Dayal D., Kusuma S., Perinataltuberculosis a case series, J. Trop. Pediatr., 2007, 53, 135-138[Crossref]
• [17] Blussé van Oud-Alblas H.J., van Vliet M.E., Kimpen J.L., deVilliers G.S., Schaaf H.S., Donald P.R., Human immunodeficiencyvirus infection in children hospitalised withtuberculosis, Ann. Trop. Paediatr., 2002, 22, 115–123[Crossref]
• [18] Schaaf H.S., Beyers N., Gie R.P., Nel E.D., Smuts N.A., Scøtt F.E.,et al., Respiratory tuberculosis in childhood: the diagnosticvalue of clinical features and special investigations, Pediatr.Infect. Dis. J., 1995, 14, 189-194[Crossref]
• [19] Pillay T., Sturm A.W., Khan M. et al., Vertical transmission ofMycobacterium tuberculosis in Kwa Zulu Natal. Impact of HIV-1co-infection, Int. J. Tuberc. Lung. Dis., 2004, 8, 59–69
• [20] Cantewel M.F., Shehad Z.M., Castelo A.M., Adhikari M.,Moodley J., Connolly C., et al., Brief report: congenitaltuberculosis. N. Engl. J. Med., 1994, 14, 1051-1054[Crossref]
• [21] Palme I.B., Gudetta B., Bruchfeld J., Muhe L., Giesecke J.,Impact of human immunodeficiency virus 1 infection on clinicalpresentation, treatment outcome and survival in a cohort ofEthiopian children with tuberculosis, Pediatr. Infect. Dis. J.,2002, 21, 1053-1061
• [22] Kaufmann S.H., Ladel C.H., Role of T cell subsets in immunityagainst intracellular bacteria: experimental infectionsof knock-out mice with Listeria monocytogenes andMycobacterium bovis BCG, Immunobiology, 1994, 191, 509-519
• [23] Rekha B., Swaminathan S., Childhood tuberculosis–globalepidemiology and the impact of HIV, Paediatr. Respir.Rev., 2007, 8, 99-106[WoS][Crossref]
• [24] Buonsenso D., Valentini P., Pediatric Tuberculosis: treatmentstrategies. In book: treatment strategies: pediatrics, 2013,11-57-63
• [25] Buonsenso D., Pirronti T., Gargiullo L., Ranno O., Valentini P.,Side effects of the immune system: lessons from tuberculosisrelatedimmune reconstitution inflammatory syndrome, Eur. J.Inflam., 2012, 10, 1-10
• [26] Chegou N.N., Black F.B., Kidd M., van Helden P.D., Walzl G.,Host markers in Quantiferon supernatants differentiate activeTB from latent TB infection: preliminary report, BMC. Pulm.Med., 2009, 16, 9-21
• [27] Duarte R., Tavares E., Miranda A., Carvalho A., Tuberculosisin a child–search for the infected adult nearby; case report,Portugal, 2007, Euro Surveill., 2009, 10, 14
• [28] Buonsenso D., Lancella L., Delogu G., Krzysztofiak A., Testa A.,Ranno O., et al., A twenty-year retrospective study of pediatrictuberculosis in two tertiary hospitals in Rome, Pediatr. Infect.Dis. J., 2012, 31, 1022-1026[WoS]

Identyfikatory

DOI

10.1515/med-2015-0012